论文部分内容阅读
本文综述杧果的生理病害.根据文献报道,描述了杧果果肉病害的几个术语,如软鼻病、胶状物种子、海绵状组织,并考虑到这些病害之间的相似性.同时,阐述这些病害的发生率品种感病及其地理分布.世界上大多数主要杧果种植区均发生这些生理病害;由于全世界的杧果生产在扩大,且国际贸易中需保证优质果实,因此,增加了这些病害的重要性。迄今,尚未能鉴别出这些病害的起因,因为果肉病害与特定因子之间缺乏相关性。至于是否推迟或加速成熟会增加或减少果肉病害的发生,以及是否早、中或晚熟果实更易感病,存在着矛盾的证据.一般说来,从所报道的结果表明,大果和成熟时采收的果实比未充分成熟的果实更易发生病害.特定种植地区和季节效应也被认为会影响病害的发生。病原菌侵染引起的组织病害可能性不大。营养失调,尤其是缺铁,可能是一个重要因素,但缺乏有力的证据.尚未确定防治杧果生理病害的方法.讨论了今后探明生理病害病因以及开发防治生理病害技术的研究领域.
In this paper, the physiological diseases of mango fruits are summarized.According to the literature, several terms of mango fruit diseases such as soft nose disease, jelly seeds and spongy tissues are described, and the similarities between these diseases are considered.At the same time, Describing the prevalence of these diseases, their susceptibility to the disease and its geographical distribution, these physiological diseases occur in most major mango-growing areas in the world; as mango production in the world is expanding and international trade requires quality fruit, Increases the importance of these diseases. To date, the causes of these diseases have not been identified because there is a lack of correlation between the disease and specific factors. As to whether the postponement or accelerated maturity will increase or decrease the incidence of pulp diseases and whether early, middle or late-maturing fruit is more susceptible to the disease, there is contradictory evidence. Generally speaking, the reported results indicate that large and mature fruits The harvested fruit is more susceptible to disease than the less ripe fruit, and the specific planting areas and seasonal effects are also thought to influence the occurrence of the disease. Organizational disease caused by pathogen infection is unlikely. Malnutrition, especially iron deficiency, may be an important factor, but there is no strong evidence for this. The methods for preventing and controlling physiological diseases of mango have not been established. The future research fields to identify the causes of physiological diseases and to develop technologies for the prevention and control of physiological diseases are discussed.